High Blood Pressure — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for high blood pressure. 6 active patents protecting 1 drugs from 1+ originators. First major cliff: 2029. Daily refresh.

1
Approved drugs
6
Active US patents
63/100
Avg vulnerability
—
Annual revenue covered

Originators in High Blood Pressure

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Idorsia 6 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating high blood pressure. Each bar = one year. Y-axis scaled to peak year (4 patents).

1
29
1
37
4
38

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Tryvio
APROCITENTAN
 Idorsia 6 63 — 2029-09-21

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
8324232 Tryvio method of use 81 2029-09-21
11174247 Tryvio method of use 75 2037-11-06
11787782 Tryvio method of use 75 2038-03-02
11680058 Tryvio method of use 75 2038-07-26
12297189 Tryvio formulation 55 2038-02-26
10919881 Tryvio composition of matter 17 2038-02-26

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
10919881 Tryvio composition of matter 17 2038-02-26
12297189 Tryvio formulation 55 2038-02-26
11680058 Tryvio method of use 75 2038-07-26
11787782 Tryvio method of use 75 2038-03-02
11174247 Tryvio method of use 75 2037-11-06
8324232 Tryvio method of use 81 2029-09-21

Related